Keyphrases
B-cell Acute Lymphoblastic Leukemia (B-ALL)
100%
Gene mutation
100%
Chk2
100%
Tisagenlecleucel
100%
Germ Cells
71%
Hematopoietic Cell Transplant
28%
Chimeric Antigen Receptor T-cell Therapy
28%
Cell Therapy
14%
Hematological Malignancies
14%
Risk Factors
14%
Malignancy
14%
High Risk
14%
Central Lymph Node
14%
Metastatic Disease
14%
DNA Damage
14%
National Cancer Institute
14%
Solid Tumors
14%
Conventional Chemotherapy
14%
Remission
14%
Pediatric Patients
14%
Children's Oncology Group
14%
Complete Remission
14%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
14%
Conventional Radiation Therapy
14%
Relapsed or Refractory
14%
Family History
14%
Secondary Malignancy
14%
Extended Family
14%
Induction Chemotherapy
14%
Total Thyroidectomy
14%
Lymph Node Biopsy
14%
Fluorescence in Situ Hybridization
14%
Cytogenetic Analysis
14%
White Blood Cell Count
14%
Presenting Manifestation
14%
Normal Karyotype
14%
CRLF2
14%
Biological Mothers
14%
Maternal Uncle
14%
CD19
14%
Fraternal Twins
14%
Papillary Thyroid Carcinoma
14%
Extramedullary
14%
Biological Father
14%
Anaplastic Thyroid Cancer
14%
Extramedullary Disease
14%
Radioactive Iodine Therapy
14%
CD19 Antigen
14%
P2RY8
14%
Genetic Panel
14%
Familial mutations
14%
SDHAF2
14%
Medicine and Dentistry
Gene Mutation
100%
Acute Lymphoblastic Leukemia
100%
Checkpoint Kinase 2
100%
Germ Cell
71%
Hematopoietic Cell
28%
Cancer
28%
Chromosome Analysis
14%
Metastatic Carcinoma
14%
Leukocyte
14%
Pediatrics Patient
14%
Fluorescence in Situ Hybridization
14%
Case Presentation
14%
Hematologic Malignancy
14%
Thyroidectomy
14%
Papillary Thyroid Cancer
14%
Lymph Node Biopsy
14%
Cell Therapy
14%
Malignant Neoplasm
14%
Family History
14%
Solid Malignant Neoplasm
14%
DNA Damage
14%
Cerebrospinal Fluid
14%
Dizygotic Twins
14%
Cyclin Dependent Kinase Inhibitor 2A
14%
Radioactive Iodine
14%
Anaplastic Thyroid Carcinoma
14%
CD19 Antigen
14%
Chimeric Antigen Receptor T-Cell Immunotherapy
14%
Chimeric Antigen Receptor
14%
Oncology
14%
Cell Count
14%
Central Lymph Nodes
14%
Induction Chemotherapy
14%
Karyotype
14%
Diseases
14%
Immunology and Microbiology
Gene Mutation
100%
Germ Cell
71%
Hematopoietic Cell
28%
Thyroid
28%
Chimeric Antigen Receptor T-Cell Therapy
14%
Cerebrospinal Fluid
14%
DNA Damage
14%
CD19
14%
Chimeric Antigen Receptor
14%
Leukocyte Count
14%
Dizygotic Twins
14%
CD19 Antigen
14%
Lymph Node
14%
Tincture of Iodine
14%
Fluorescence in Situ Hybridization
14%
Karyotype
14%